On May 26, 2026, Illinois Attorney General Kwame Raoul said the state has locked in an $8.25 million settlement with Mylan Inc., the company that sells the EpiPen, closing out allegations that the ...
Raoul secures $8.25 million Mylan settlement over EpiPen anticompetitive practices affecting Illinois Medicaid and state ...
After weeks of controversy, the Centers for Medicare and Medicaid Services formally blamed Mylan Pharmaceuticals for misclassifying EpiPen with the Medicaid Drug Rebate Program. Under the program, ...
Mylan CEO Heather Bresch survived an ouster attempt by angry shareholders. Heather Bresch is willing to participate in a high-profile industry conference this week, but not testify before Congress — ...
Pharmaceutical firm Mylan is dramatically expanding a nationwide recall of some blood pressure medications after detecting trace amounts of a chemical linked to cancer. The recalled products all ...
Source: Teva Pharmaceutical via Facebook. What: Shares of Mylan, a branded-drug developer that is alsoa large player in the generic drug market, surged by 22% in April, according to data from S&P ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results